OTC Nasacort to Get FDA Panel Scrutiny

WASHINGTON (MedPage Today) -- FDA staff reviewers had few questions about making allergy nasal spray triamcinolone acetonide (Nasacort AQ) available for over-the-counter sales; later this week an advisory committee will look at the issue.
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news